Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.
Aytu BioScience, Inc is a biotechnology business based in the US. Aytu BioScience shares (AYTU) are listed on the NASDAQ and all prices are listed in US Dollars. Aytu BioScience employs 75 staff and has a trailing 12-month revenue of around USD$27.6 million.
Since the stock market crash in March caused by coronavirus, Aytu BioScience's share price has had significant positive movement.
Its last market close was USD$1.02, which is 26.18% up on its pre-crash value of USD$0.753 and 204.30% up on the lowest point reached during the March crash when the shares fell as low as USD$0.3352.
If you had bought USD$1,000 worth of Aytu BioScience shares at the start of February 2020, those shares would have been worth USD$2,630.10 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,434.60.
|Latest market close||USD$1.02|
|52-week range||USD$0.3352 - USD$2.99|
|50-day moving average||USD$1.1623|
|200-day moving average||USD$1.3723|
|Wall St. target price||USD$2.63|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-3.481|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-10-22)||0.99%|
|1 month (2020-09-29)||-15.00%|
|3 months (2020-07-29)||-25.55%|
|6 months (2020-04-29)||-37.04%|
|1 year (2019-10-29)||-4.67%|
|2 years (2018-10-29)||-13.56%|
|3 years (2017-10-27)||-72.43%|
|5 years (2015-10-29)||-77.33%|
|Revenue TTM||USD$27.6 million|
|Gross profit TTM||USD$20.1 million|
|Return on assets TTM||-13.49%|
|Return on equity TTM||-26.68%|
|Market capitalisation||USD$128.4 million|
TTM: trailing 12 months
There are currently 11.5 million Aytu BioScience shares held short by investors – that's known as Aytu BioScience's "short interest". This figure is 128.9% up from 5.0 million last month.
There are a few different ways that this level of interest in shorting Aytu BioScience shares can be evaluated.
Aytu BioScience's "short interest ratio" (SIR) is the quantity of Aytu BioScience shares currently shorted divided by the average quantity of Aytu BioScience shares traded daily (recently around 3.4 million). Aytu BioScience's SIR currently stands at 3.33. In other words for every 100,000 Aytu BioScience shares traded daily on the market, roughly 3330 shares are currently held short.
However Aytu BioScience's short interest can also be evaluated against the total number of Aytu BioScience shares, or, against the total number of tradable Aytu BioScience shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aytu BioScience's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 Aytu BioScience shares in existence, roughly 90 shares are currently held short) or 0.0929% of the tradable shares (for every 100,000 tradable Aytu BioScience shares, roughly 93 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aytu BioScience.
Find out more about how you can short Aytu BioScience stock.
We're not expecting Aytu BioScience to pay a dividend over the next 12 months.
Aytu BioScience's shares were split on a 1:20 basis on 13 August 2018. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aytu BioScience shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Aytu BioScience shares which in turn could have impacted Aytu BioScience's share price.
Over the last 12 months, Aytu BioScience's shares have ranged in value from as little as $0.3352 up to $2.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aytu BioScience's is 0.1942. This would suggest that Aytu BioScience's shares are less volatile than average (for this exchange).
Aytu BioScience, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension. It also offers ZolpiMist, an oral spray for the treatment of insomnia; and MiOXSYS, an in vitro diagnostic semen analysis test that is used in the measurement of static oxidation reduction potential in human semen. Aytu BioScience, Inc. is based in Englewood, Colorado.
Steps to owning and managing WK, with 24-hour and historical pricing before you buy.
Steps to owning and managing HCN, with 24-hour and historical pricing before you buy.
Steps to owning and managing VEL, with 24-hour and historical pricing before you buy.
Steps to owning and managing LEA, with 24-hour and historical pricing before you buy.
Steps to owning and managing LUB, with 24-hour and historical pricing before you buy.
Steps to owning and managing HCSG, with 24-hour and historical pricing before you buy.
Steps to owning and managing LAWS, with 24-hour and historical pricing before you buy.
Steps to owning and managing SWIR, with 24-hour and historical pricing before you buy.
Steps to owning and managing PFBC, with 24-hour and historical pricing before you buy.
Steps to owning and managing CSIQ, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.